Outset Medical (OM) Cash from Operations (2019 - 2026)

Outset Medical (OM) has reported Cash from Operations for 8 consecutive years, with -$9.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations fell 99.77% year-over-year to -$9.6 million in Q2 2026; TTM through Jun 2026 was -$38.3 million, a 43.26% increase from a year earlier, with the FY2025 full-year figure at -$46.3 million, up 60.17% from the prior year.
• Cash from Operations was -$9.6 million for Q2 2026 at Outset Medical, up from -$12.8 million in the prior quarter.
• Over five years, Cash from Operations peaked at -$4.8 million in Q2 2025 and troughed at -$45.9 million in Q1 2024.
• A 5-year average of -$25.7 million and a median of -$26.9 million in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 85.53% in 2025 and sank 99.77% in 2026, its largest moves.
• Over 5 years, Cash from Operations stood at -$34.5 million in 2022, then advanced by 29.17% to -$24.4 million in 2023, then soared by 32.54% to -$16.5 million in 2024, then surged by 42.25% to -$9.5 million in 2025, then slipped by 1.2% to -$9.6 million in 2026.
• The last three Cash from Operations figures came in at -$9.6 million (Q2 2026), -$12.8 million (Q1 2026), and -$9.5 million (Q4 2025), per Business Quant data.